Bacterial Vaginosis
Bacterial Vaginosis


Something not right down there? You are not alone – vaginal discomfort and discharge are common complaints of women through all stages of life.1a
Back to top
Overview of condition
Bacterial Vaginosis (BV) is associated with a disturbance in the normal vaginal flora.3g It is characterized by an unpleasant vaginal “fishy” odour and off-white, greyish, thin, homogenous vaginal discharge. 2b,5b
Back to top
Causes and risk factors
The healthy vagina has a balance of various organisms, both bacteria and yeasts. When conditions change in the vagina (antibiotics, douching) either the yeasts can predominate causing thrush or bacteria, causing bacterial vaginosis. Note these are not sexually transmitted infections/diseases (STI/STDs) per se, which is the introduction of organisms not normally found in the vagina. Normal vaginal bacteria include a high proportion of bacteria known as Lactobacilli which keep the pH of the vagina acidic.1n,4d It is this acidity that suppresses the overgrowth of organisms normally present, but in small amounts in the vagina.1n Change in the vaginal conditions can lead to a loss of the Lactobacillus dominance in the vagina, leading to alkalization. In an alkaline environment, these lesser bacteria, such as Gardnerella vaginalis, flourish producing the characteristic vaginal discharge symptoms. Factors that alter the vaginal pH, introduce “normal” bacteria but which upset the balance, or cause microtrauma, increase the risk of developing BV:1i
- New or multiple sex partners
- Frequent douching
- Intrauterine contraceptive devices (IUDs)
- Pregnancy
Untreated BV can lead to serious risks:3d,4a
- Increased risk of HIV
- Increased risk of sexually transmitted infections (STIs)
- In pregnant women, BV increases the risk of miscarriage, preterm labour and preterm delivery, as well as increasing the risk of complications after birth such as endometritis (inflammation of the lining of the uterus) and wound infections.
Back to top
Signs and Symptoms
There are three main types of vaginal infection.
- Bacterial vaginosis is due to an overgrowth of normal vaginal bacteria
- A yeast infection (thrush) is due to an overgrown of yeasts natuarally occurring in the vagina
- STIs (due to various organisms such as Trichomonas, gonorrhea, chlamydia)

- Unpleasant “fishy” odour.
- Off-white, greyish, thin, homogenous discharge.
- Itching and inflammation are not usually present.
Back to top
How the condition impacts quality of life
- BV is the most common cause of vaginal discharge or vaginitis in women of childbearing age.2a
- Bacterial vaginosis (BV) affects 1 in 3 women.1d,3c,4b
- Many women with BV have no symptoms.4c
- The majority of patients with vaginal symptoms use over-the-counter antifungal medication which does not treat BV.1c


Back to top
Treatment
Antibacterial treatment is available in
- Vaginal tablets
- Vaginal cream
Medical References
- Hildebrand JP, Kansagor AT. Vaginitis. [Updated 2022 Feb 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470302/.
- Sobel JD. Vaginitis. The New England Journal of Medicine.1997;337(26):1896-1903.
- Bilardi JE, Walker S, Temple-Smith M, et al. The burden of bacterial vaginosis: women's experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis. PLOS ONE 2013;8(9):e74378. doi:10.1371/journal.pone.0074378.
- Koumans EH, Sternberg M, Bruce C, et al. The Prevalence of bacterial vaginosis in the United States, 2001 -2004; associations with symptoms, sexual behaviors, and reproductive health. Sexually Transmitted Diseases 2007;34(11):864 -869. DOI: 10.1097/OLQ.0b013e318074e565.
- Mendling W, Weissenbacher ER, Gerber S et al. Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review. Arch Gynecol Obstet 2016;293:469-484. DOI 10.1007/s00404-015-3914-8.
- Minkin MJ, Maamari R and Reiter S. Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy International Journal of Women’s Health 2013:5 133–139.
- Weissmann-Brenner A, Bayevsky T, Yoles I. Compliance to vaginal treatment—tablets versus cream: a retrospective 9 years study. Menopause 2017;24(1):73-76.
October 5, 2021
Content Disclaimer:
You understand and acknowledge that all users of the Dis-Chem website or app are responsible for their own medical care, treatment, and oversight. All of the content provided on the website, are for INFORMATIONAL PURPOSES ONLY and DOES NOT CONSTITUTE THE PROVIDING OF MEDICAL ADVICE and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment. The content is not intended to establish a standard of care to be followed by a user of the website. You understand and acknowledge that you should always seek the advice of your physician or other qualified health provider with any questions or concerns you may have regarding your health. You also understand and acknowledge that you should never disregard or delay seeking medical advice relating to treatment or standard of care because of information contained in or transmitted through the website. Medical information changes constantly. Therefore the information on this website or on the linked websites should not be considered current, complete or exhaustive, nor should you rely on such information to recommend a course of treatment for you or any other individual. Reliance on any information provided on this website or any linked websites is solely at your own risk.